Imamura M - Search Results

1

Early detection of haemobilia associated with percutaneous ethanol injection for hepatocellular carcinoma.

Obi S, Shiratori Y, Shiina S, Hamamura K, Kato N, Imamura M, Teratani T, Sato S, Komatsu Y, Kawabe T, Omata M. Obi S, et al. Among authors: imamura m. Eur J Gastroenterol Hepatol. 2000 Mar;12(3):285-90. doi: 10.1097/00042737-200012030-00005. Eur J Gastroenterol Hepatol. 2000. PMID: 10750648

2

[Percutaneous ethanol injection therapy for small hepatocellular carcinoma].

Shiina S, Imamura M, Obi S, Teratani T, Kanai F, Kato N, Niwa Y, Okudaira T, Payawal DA, Tateishi R, Shiratori Y, Omata M. Shiina S, et al. Among authors: imamura m. Gan To Kagaku Ryoho. 1996 Jun;23(7):835-9. Gan To Kagaku Ryoho. 1996. PMID: 8678530 Japanese.

3

Percutaneous hepatic infarction therapy for hepatocellular carcinoma.

Imamura M, Shiratori Y, Sato S, Obi S, Okudaira T, Teratani T, Kato N, Shiina S, Omata M. Imamura M, et al. AJR Am J Roentgenol. 1998 Oct;171(4):1031-5. doi: 10.2214/ajr.171.4.9762991. AJR Am J Roentgenol. 1998. PMID: 9762991

4

Power Doppler sonography for hepatocellular carcinoma: factors affecting the power Doppler signals of the tumors.

Imamura M, Shiratori Y, Shiina S, Sato S, Obi S, Okudaira T, Teratani T, Kato N, Akahane M, Ohtomo K, Minami M, Omata M. Imamura M, et al. Liver. 1998 Dec;18(6):427-33. doi: 10.1111/j.1600-0676.1998.tb00828.x. Liver. 1998. PMID: 9869398

5

Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma.

Matsumura M, Shiratori Y, Niwa Y, Tanaka T, Ogura K, Okudaira T, Imamura M, Okano K, Shiina S, Omata M. Matsumura M, et al. Among authors: imamura m. J Hepatol. 1999 Aug;31(2):332-9. doi: 10.1016/s0168-8278(99)80232-3. J Hepatol. 1999. PMID: 10453948

6

Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion.

Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, Hamamura K, Imai Y, Yoshida H, Shiina S, Omata M. Koike Y, et al. Among authors: imamura m. Hepatology. 2000 Dec;32(6):1216-23. doi: 10.1053/jhep.2000.20237. Hepatology. 2000. PMID: 11093727

7

Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients.

Sato S, Shiratori Y, Imamura M, Teratani T, Obi S, Koike Y, Imai Y, Yoshida H, Shiina S, Omata M. Sato S, et al. Among authors: imamura m. J Hepatol. 2001 Aug;35(2):225-34. doi: 10.1016/s0168-8278(01)00083-6. J Hepatol. 2001. PMID: 11580145

8

[Management of complications associated with local ablation therapy for hepatocellular carcinoma].

Obi S, Shiina S, Imamura M, Teratani T, Satoh S, Koike Y, Ishikawa T, Akamatsu M, Fujishima T, Tateishi R, Omata M. Obi S, et al. Among authors: imamura m. Nihon Rinsho. 2001 Oct;59 Suppl 6:606-11. Nihon Rinsho. 2001. PMID: 11762021 Review. Japanese. No abstract available.

9

Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.

Niwa Y, Matsumura M, Shiratori Y, Imamura M, Kato N, Shiina S, Okudaira T, Ikeda Y, Inoue T, Omata M. Niwa Y, et al. Among authors: imamura m. Hepatology. 1996 Jun;23(6):1384-92. doi: 10.1053/jhep.1996.v23.pm0008675155. Hepatology. 1996. PMID: 8675155

10

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M. Shiratori Y, et al. Among authors: imamura m. Cancer. 1997 Dec 1;80(11):2060-7. Cancer. 1997. PMID: 9392327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,374 results

Search Page

Filters